Scientists Able to Measure Infection Risk from a Droplet of Blood

By Petrina Smith
Thursday, 28 November, 2013



[contextly_auto_sidebar id="WQ3wU7miaxetzIriNqACfi2RemxWIwYf"]

A team of researchers at BioMEMS resource centre at Massachesetts General hospital have discovered a way to measure infection risk from a droplet of blood in a few minutes.


Neutrophils are a vital part of the body’s immune system. Recognized as the most abundant type of white blood cell present in human blood, neutrophils function primarily as the body’s first line of defense against infection and inflammation. Within minutes of stimulation, neutrophils migrate from the blood to tissue where they accumulate at sites of infection. One of the most common lab tests ordered on a regular basis is the counting of neutrophils in the blood (absolute neutrophil count).


 “However, simply counting the neutrophils may not be enough in many cases," says Dr Daniel Irimia, Assistant Professor at the BioMEMS Resource Center at Massachusetts General Hospital. " If neutrophils do not migrate well and cannot reach inside the tissues, this situation could have the same consequences as a low neutrophil count." The team recently designed miniaturized silicon-based devices that can be used to measure neutrophils’ migration patterns from just a finger prick of blood in a few minutes. He also says, “The device was designed such that probing neutrophil mobility becomes extremely easy to perform.”


 Current methods to measure neutrophil functions involve separating the neutrophils from the whole blood. This separation process can take up to two hours to prepare and execute by skilled lab personnel. In a clinical context, such as cases of patients with burn injuries, this is not ideal as priorities can shift quickly throughout the day.
 By being able to measure the risk for infections that a particular patient has at a particular time, in a matter of minutes, from just a droplet of blood, is a significant improvement and one that will improve current treatment.
 For more information on this research, refer to: http://www.worldscientific.com/doi/pdf/10.1142/S2339547813500040
 
Related Articles

Same medication, different price

Australia has ranked #40 in an index of 50 countries in a global study comparing the cost of some...

Call to lower Australian LDL-C targets

The release of new European guidelines on dyslipidaemias has called Australia’s LDL-C...

Australian research leading the charge in malaria elimination

Professor Brendan Crabb received the 2019 GSK Award for Research Excellence for his research on...


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd